Category: Covid-19

Reuse our editable social media cards to spread the word on vaccines for European Immunization Week 2023!

Download and reuse our social media card on vaccines for European Immunization Week 2023.

This document offers an overview of the available scientific evidence and epidemiological situation and provides public health considerations to support discussions and decisions on the planning and implementation of COVID-19 vaccination campaigns for 2023.

To decrease the impact of COVID-19, and related hospitalisations and mortality, countries should plan for a continued roll-out of COVID vaccines in 2023.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 March – 1 April 2023 and includes updates on Iatrogenic botulism exposure in Türkiye, COVID-19, group A streptococcal infection, influenza, swine influenza. Marburg virus disease and poliomyelitis.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.

This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon pre-existing ECDC guidance and follows a methodological approach combining interactive workshops and interviews. The Annexes feature practical implementation tools.

ECDC has published an updated guidance on designing and conducting after-action reviews (AARs) of the public health response to the COVID-19 pandemic.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A streptococcal infection, influenza, chikungunya and dengue, and influenza B among young people.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza, diphtheria, measles, iatrogenic botulism, poliomyelitis, and autochthonous Dengue.